Hope Care raises €6M Series A to scale remote patient monitoring

Portuguese healthtech Hope Care has closed a €6 million Series A led by Iberis Capital, with Vieira de Matos – VDM Capital and existing shareholder Buenavista Equity Partners, to roll its remote patient monitoring platform out across Europe.

Healthcare systems everywhere are short of staff and long on chronic patients – and yet one of the most convincing answers announced this week comes not from London or Berlin, but from Portugal. Below, I lay out the round, the fourteen-year build behind it, and why a home-grown lead investor is the most interesting line in the announcement.

A Portuguese lead for a Portuguese scale-up

Hope Care announced on 8 September 2026 that it has raised a €6 million Series A. Iberis Capital leads, joined by Vieira de Matos – VDM Capital and Buenavista Equity Partners, which was already a shareholder and followed on.

The company says the money will go to accelerating European expansion, strengthening its commercial and operational teams, and deploying remote patient monitoring programmes in its key markets. That expansion is already in motion: a German subsidiary, Hope Care GmbH, is set up in Erlangen with a first deployment planned for October 2026, and a Romanian entity is being established this month, per the announcement. The company is already active in Portugal, France and Switzerland.

For scale, this lands in the same week our database logged Octave.energy’s €10M Series A in Belgian battery storage and Cato’s €6M seed in Italian govtech – a €6M Series A is a measured cheque, not a land grab.

Fourteen years to reach 45% of Portugal’s health service

Hope Care is not a pandemic-era telehealth pivot. Founded in 2012 by José Paulo Carvalho, the company spent over a decade building OpMA, a regulated platform that pulls together medical device data, patient-reported outcomes and clinical workflows so that hospitals can design and run digital care programmes for chronic conditions.

The traction is the story. Per the company’s announcement, OpMA runs in 15 of Portugal’s Local Health Units, covering roughly 45% of national health service (SNS) users, plus the regional health services of Madeira and the Azores. Its COPD programme reported a 76% reduction in hospital days and a 74% reduction in emergency visits, worth €4,811 in annual savings per patient over 12 months across a 43-patient cohort. Small cohort, real numbers – the kind health systems actually procure on. First-half 2026 sales came in at 2.5 times the first half of 2025, per the company.

The $110bn market hiding in plain sight

Remote patient monitoring is one of those categories that sounds niche and is anything but. Grand View Research (July 2025) puts the global remote patient monitoring market on course for $110.71 billion by 2033, growing at a 19.8% CAGR from 2025. Europe is the second-largest region in that forecast, and its public health systems – stretched thin on clinicians, drowning in chronic disease – are exactly where the economics of monitoring at home beat another hospital bed.

The good news is that Europe’s fragmented healthcare map, usually a roadblock, is an advantage here: a company that has cleared procurement in Portugal, France and Switzerland has already learned three regulatory dialects. Germany and Romania are hard markets, but they are hard for everyone – and Hope Care arrives with public-system references most competitors cannot show.

What a home-market Series A signals

So what does this round tell us beyond one company’s good week? Three things worth watching.

First, the lead. Iberis Capital backing a Portuguese healthtech to go European is the pattern we keep asking for: domestic capital scaling domestic champions instead of waiting for a foreign fund to validate them. Second, the vintage: 2012-founded, revenue-first, raising a Series A in 2026 – a reminder that in regulated health, the overnight successes are fourteen years old. Third, the destination markets: Erlangen and Bucharest, not another office in London, which says the next wave of European health expansion is following the patients, not the capital.

We track every European round like this one in our fundraising database, and Portuguese healthtech has been one of its quieter but steadier lines this year.

Europe does not need another pilot programme; it needs deployments that survive procurement. Hope Care just raised €6 million saying it can deliver exactly that – now let’s watch it prove it in German.